Bioptik Technology (ROCO:4161) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4161 Bioptik Technology Inc ROCO:4161
69 GF Score
Price NT$21.60
GF Value NT$28.93
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bioptik Technology Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

ROCO:4161
69GF Score
Bioptik Technology Inc ROCO:4161
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioptik Technology (ROCO:4161) Overvalued in 2026?

Based on GuruFocus' analysis, Bioptik Technology stock appears to be undervalued. The current stock price of NT$21.60 is trading 25.3% below its estimated GF Value™ of NT$28.93. GuruFocus considers Bioptik Technology to be Modestly Undervalued.

Key valuation signals for ROCO:4161:

  • Dividends Received:
  • GF Value™: NT$28.93 vs. price of NT$21.60 (25.3% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioptik Technology Business Description

Address No.188, Zhonghua South Road, Miaoli County, Zhunan, TWN, 35057
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.
69GF Score

Get the complete analysis for ROCO:4161

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$21.60
Price
NT$28.93
GF Value